Lorcaserin Extended-Release Tablets and Sulfur hexafluoride lipid type a microspheres Injection, Intravenous
Determining the interaction of Lorcaserin Extended-Release Tablets and Sulfur hexafluoride lipid type a microspheres Injection, Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: sulfur hexafluoride
Brand name: Lumason
Synonyms: Sulfur hexafluoride
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Sulfur topical
- Lorcaserin Extended-Release Tablets-Sulindac
- Lorcaserin Extended-Release Tablets-Sulmasque Topical
- Lorcaserin Extended-Release Tablets-Sulpho-Lac Soap
- Lorcaserin Extended-Release Tablets-Sulpho-Lac Topical
- Lorcaserin Extended-Release Tablets-Sumadan
- Sulfur hexafluoride lipid type a microspheres Injection, Intravenous-Lorcaserin Hydrochloride
- Sulfur hexafluoride lipid type a microspheres Injection, Intravenous-Lorcaserin Tablets
- Sulfur hexafluoride lipid type a microspheres Injection, Intravenous-Lorcet
- Sulfur hexafluoride lipid type a microspheres Injection, Intravenous-Lorcet Plus
- Sulfur hexafluoride lipid type a microspheres Injection, Intravenous-Lorcet Tablets
- Sulfur hexafluoride lipid type a microspheres Injection, Intravenous-Lorlatinib